van Rooijen & Partners here describes a selection of projects, which may suit your collaboration, in-licensing or acquisition needs.

• Licensing option for treatment of peripheral artery disease. >> more


• Aptamers as tools for accelerated target validation and drug discovery. >> more


• The universal blood test tube - a unique method for simultaneous blood analysis. >> more


• Proteomic and genomic targets for CNS diseases identified in the blood brain barrier. >> more

Deals that were recently closed:

• Inhibitors of various steps in the Rho-pathway for CNS indications.


• The key patents on the repulsive guidance molecule and its receptor.


• Proteomic and genomic targets for CNS diseases identified in the blood brain barrier.


• Multiplexing technology. Addressing novel applications in nucleic acid diagnostics.


• Designed liposomes to target drug delivery to tumor tissue or to tumor vasculature. An approach to optimise marketed anticancer drugs.


• Designed liposomes for anti-tumor immunisation.


• Bi-specific single-chain antibodies for anti-tumor therapy.

If you are seeking to acquire or in-license projects or products, you can also directly express your interest. We may have an ongoing project which is not published and which may fit your needs. Alternatively van Rooijen & Partners can pro-actively support in identifying such project or product for you.

Feel free to contact us using this form, by e-mail, or phone at +49-8847-699726.